Pluri Inc. — Share Issue/Capital Change 2026

Mar 26, 2026

_________ false

פלורי אינק	2 381
PLURI INC
Corporation no: C12337-2001	16338
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C003 ( Public )		Reported via MAGNA:	26/03/2026
	www.isa.gov.il			www.tase.co.il				Reference:	2026-02-027773	Time of broadcast: 12:09 12:09

---

The corporation scheduled the publication of the report to 26/03/2026 14:30Other Report or AnnouncementRegulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report on	הנפקה פרטית לחברה בבעלות יו"ר הדירקטוריון

PR_Pluri_Inc_-_March_26_2026_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 06/08/2024
Address: Matam Park 5 , Haifa 31905   ISRAEL , Tel: 074-7107171 , Fax: 074-7107172
E-mail address: Info@Pluristem.Com   Company site: www.pluristem.com
Previous names of reporting entity: PLURISTEM THERAPEUTICS INC
Name of the Signatory: Gal Hagit Position of Signatory in the reporting corporation: General Counsel & Corporate Secretary Name of Employer Company:
Address: Matam Park 5 , Haifa 3508409 Telephone: 074-7108600 Facsimile: 074-7107172 E-mail: legalnotices@pluri-biotech.com 1